Skip to main content
EU-Startups· Rahul Raj·· 8 days agoSame newsAI Score62

SRTD Biotech raises €31.5M seed for precision mRNA therapies

Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells

AI Overview

Jülich-based SRTD Biotech closed an oversubscribed €31.5M seed round led by Mérieux Equity Partners.

Same story, shown in Top Deals《SRTD Biotech raises €31.5M seed for marker-triggered RNA therapies》

Source:EU-Startups · eu-startups.com

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing